Propensity score matching analysis to comparing cisplatin versus nedaplatin based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer

This study evaluated the efficacy and safety of cisplatin and nedaplatin in three-week doublet agent concurrent chemoradiotherapy (CCRT) for patients with locally advanced cervical cancer (LACC). We retrospectively enrolled patients with stage IIB-IIIC2 cervical cancer who received doublet agent CCR...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yue, Fan, Shasha, Shan, Minjie, Zou, Wen, Feng, Yeqian, Hou, Tao, Liu, Xianling, Wang, Jingjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250460/
https://www.ncbi.nlm.nih.gov/pubmed/37291330
http://dx.doi.org/10.1038/s41598-023-36433-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250460/
https://www.ncbi.nlm.nih.gov/pubmed/37291330
http://dx.doi.org/10.1038/s41598-023-36433-5

Ejemplares similares